Research
Hormonal
SGLT2 inhibitors reduce the risk of developing diabetes in high-risk patients with heart failure or chronic kidney disease.
If you have heart failure or kidney disease, even without diabetes, ask your doctor if an SGLT2 inhibitor is right for you. These drugs protect your heart and kidneys and may also prevent diabetes.
GoodSupportsHIGH confidence
SGLT2 inhibitors have shown protective effects against hospitalization for heart failure and chronic kidney disease, and may prevent diabetes in high-risk patients with heart failure and kidney disease.
Why this rating
Based on cited observational and trial data.
Source
Extent of Role: Anti-Diabetic Medications
Jun Hwa Hong · Journal of Korean Diabetes · 2022
DOI 10.4093/jkd.2022.23.3.153
narrative_review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- SGLT2 inhibitors and GLP-1 receptor agonists reduce hospitalization for heart failure, chronic kidney disease, and atherosclerotic cardiovascular disease in patients with type 2 diabetes.Strong
- GLP-1 receptor agonists (specifically high-dose liraglutide) prevent the progression from prediabetes to type 2 diabetes in obese individuals.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →